1. Home
  2. SMWB vs VIR Comparison

SMWB vs VIR Comparison

Compare SMWB & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Similarweb Ltd.

SMWB

Similarweb Ltd.

HOLD

Current Price

$7.27

Market Cap

747.7M

Sector

Technology

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$6.01

Market Cap

825.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMWB
VIR
Founded
2007
2016
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
747.7M
825.0M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
SMWB
VIR
Price
$7.27
$6.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
11
Target Price
$14.38
$25.73
AVG Volume (30 Days)
317.5K
1.7M
Earning Date
02-10-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$275,429,000.00
$16,860,000.00
Revenue This Year
$16.89
N/A
Revenue Next Year
$13.80
$46.25
P/E Ratio
N/A
N/A
Revenue Growth
14.25
N/A
52 Week Low
$6.36
$4.16
52 Week High
$17.64
$14.45

Technical Indicators

Market Signals
Indicator
SMWB
VIR
Relative Strength Index (RSI) 46.39 49.01
Support Level $6.97 $5.55
Resistance Level $7.70 $6.10
Average True Range (ATR) 0.32 0.34
MACD 0.04 -0.04
Stochastic Oscillator 49.42 37.92

Price Performance

Historical Comparison
SMWB
VIR

About SMWB Similarweb Ltd.

Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: